Article info

Download PDFPDF
Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis

Authors

  • T Yli-Kerttula aDepartment of Medicine, Turku University, Finland, bDepartment of Medical Microbiology, Turku University, cDepartment of Virology, Turku University, dSatalinna Hospital, Finland, eDepartment of Medicine, Section of Rheumatology, Tampere University Hospital, Finland, fJyväskylä Central Hospital, Finland, gStat-X, Finland PubMed articlesGoogle scholar articles
  • R Luukkainen aDepartment of Medicine, Turku University, Finland, bDepartment of Medical Microbiology, Turku University, cDepartment of Virology, Turku University, dSatalinna Hospital, Finland, eDepartment of Medicine, Section of Rheumatology, Tampere University Hospital, Finland, fJyväskylä Central Hospital, Finland, gStat-X, Finland PubMed articlesGoogle scholar articles
  • U Yli-Kerttula aDepartment of Medicine, Turku University, Finland, bDepartment of Medical Microbiology, Turku University, cDepartment of Virology, Turku University, dSatalinna Hospital, Finland, eDepartment of Medicine, Section of Rheumatology, Tampere University Hospital, Finland, fJyväskylä Central Hospital, Finland, gStat-X, Finland PubMed articlesGoogle scholar articles
  • T Möttönen aDepartment of Medicine, Turku University, Finland, bDepartment of Medical Microbiology, Turku University, cDepartment of Virology, Turku University, dSatalinna Hospital, Finland, eDepartment of Medicine, Section of Rheumatology, Tampere University Hospital, Finland, fJyväskylä Central Hospital, Finland, gStat-X, Finland PubMed articlesGoogle scholar articles
  • M Hakola aDepartment of Medicine, Turku University, Finland, bDepartment of Medical Microbiology, Turku University, cDepartment of Virology, Turku University, dSatalinna Hospital, Finland, eDepartment of Medicine, Section of Rheumatology, Tampere University Hospital, Finland, fJyväskylä Central Hospital, Finland, gStat-X, Finland PubMed articlesGoogle scholar articles
  • M Korpela aDepartment of Medicine, Turku University, Finland, bDepartment of Medical Microbiology, Turku University, cDepartment of Virology, Turku University, dSatalinna Hospital, Finland, eDepartment of Medicine, Section of Rheumatology, Tampere University Hospital, Finland, fJyväskylä Central Hospital, Finland, gStat-X, Finland PubMed articlesGoogle scholar articles
  • M Sanila aDepartment of Medicine, Turku University, Finland, bDepartment of Medical Microbiology, Turku University, cDepartment of Virology, Turku University, dSatalinna Hospital, Finland, eDepartment of Medicine, Section of Rheumatology, Tampere University Hospital, Finland, fJyväskylä Central Hospital, Finland, gStat-X, Finland PubMed articlesGoogle scholar articles
  • J Parviainen aDepartment of Medicine, Turku University, Finland, bDepartment of Medical Microbiology, Turku University, cDepartment of Virology, Turku University, dSatalinna Hospital, Finland, eDepartment of Medicine, Section of Rheumatology, Tampere University Hospital, Finland, fJyväskylä Central Hospital, Finland, gStat-X, Finland PubMed articlesGoogle scholar articles
  • J Uksila aDepartment of Medicine, Turku University, Finland, bDepartment of Medical Microbiology, Turku University, cDepartment of Virology, Turku University, dSatalinna Hospital, Finland, eDepartment of Medicine, Section of Rheumatology, Tampere University Hospital, Finland, fJyväskylä Central Hospital, Finland, gStat-X, Finland PubMed articlesGoogle scholar articles
  • R Vainionpää aDepartment of Medicine, Turku University, Finland, bDepartment of Medical Microbiology, Turku University, cDepartment of Virology, Turku University, dSatalinna Hospital, Finland, eDepartment of Medicine, Section of Rheumatology, Tampere University Hospital, Finland, fJyväskylä Central Hospital, Finland, gStat-X, Finland PubMed articlesGoogle scholar articles
  • A Toivanen aDepartment of Medicine, Turku University, Finland, bDepartment of Medical Microbiology, Turku University, cDepartment of Virology, Turku University, dSatalinna Hospital, Finland, eDepartment of Medicine, Section of Rheumatology, Tampere University Hospital, Finland, fJyväskylä Central Hospital, Finland, gStat-X, Finland PubMed articlesGoogle scholar articles
  1. Dr Timo Yli-Kerttula, Department of Medicine, Turku University, Kiinamyllynkatu 4–8, FIN-20520 Turku, Finland Email: timo.yli-kerttula{at}utu.fi
View Full Text

Citation

Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, et al
Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis

Publication history

  • Accepted January 31, 2000
  • First published July 1, 2000.
Online issue publication 
January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.